Praxis Precision Medicines

PRAXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.344 B

$298.87 -0.03%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$303.0M

Loss-making

Shares outstanding

27,919,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#38AbivaxABVX$8.91B
#39Tg TherapeuticsTGTX$8.75B
#40Praxis Precision MedicinesPRAX$8.34B
#41Spyre TherapeuticsSYRE$8.11B
#42Ionis PharmaceuticalsIONS$7.46B

What if Praxis Precision Medicines were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,084,315

Per share 3,628× higher

Bitcoin $1.72T

$61,597.58

Per share 206× higher

Nvidia $5.48T

$196,270.07

Per share 657× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Praxis Precision Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.